John R. Beaver's Insider Trades & SAST Disclosures

John R. Beaver's most recent trade in Biolase Inc was a trade of 486,255 Restricted Stock Unit done . Disclosure was reported to the exchange on June 2, 2023.

Share

Note

This is a custom search result for pattern John R. Beaver.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Biolase Inc Results Board Meeting 10-year low	John R. Beaver	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2023	486,255	688,162	-		-	Restricted Stock Unit
Biolase Inc Results Board Meeting 10-year low	John R. Beaver	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Aug 2022	31,743	201,907	-		-	Restricted Stock Unit
Biolase Inc Results Board Meeting 10-year low	John R. Beaver	Director, President & CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	28 Apr 2022	554	0	-		-	Series G Preferred Stock
Biolase Inc Results Board Meeting 10-year low	John R. Beaver	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 0.45 per share.	30 Nov 2021	70,000	621,530 (2%)	0%	0.5	31,500	Common Stock
Biolase Inc Results Board Meeting 10-year low	John R. Beaver	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 0.61 per share.	20 Aug 2021	35,000	551,530 (1%)	0%	0.6	21,350	Common Stock
Biolase Inc Results Board Meeting 10-year low	John R. Beaver	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Aug 2021	220,000	220,000	-		-	Stock Appreciation Right
Biolase Inc Results Board Meeting 10-year low	John R. Beaver	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2021	4,144,139	4,144,139	-		-	Restricted Stock Unit
Biolase Inc Results Board Meeting 10-year low	John R. Beaver	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 0.75 per share.	19 May 2021	40,000	516,530 (1%)	0%	0.8	30,000	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades